These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11387512)

  • 41. Comprehensive deep venous thrombosis prevention strategy after total-knee arthroplasty.
    Ragucci MV; Leali A; Moroz A; Fetto J
    Am J Phys Med Rehabil; 2003 Mar; 82(3):164-8. PubMed ID: 12595766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
    Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
    Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acetylsalicylic acid-renaissance with venous thrombosis? ].
    Verspohl EJ
    Med Monatsschr Pharm; 2016 Jan; 39(1):37-9. PubMed ID: 26975177
    [No Abstract]   [Full Text] [Related]  

  • 44. Ambulatory Status Protects against Venous Thromboembolism in Acute Mild Ischemic Stroke Patients.
    Sisante JF; Abraham MG; Phadnis MA; Billinger SA; Mittal MK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2496-501. PubMed ID: 27423367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
    Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients.
    Wells PS; Borah BJ; Sengupta N; Supina D; McDonald HP; Kwong LM
    Am J Manag Care; 2010 Nov; 16(11):857-63. PubMed ID: 21348557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 49. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

  • 50. Enoxaparin for the prevention of VT in acutely ill patients.
    Tseng CW; Huntington J
    J Fam Pract; 1999 Dec; 48(12):940-1. PubMed ID: 10628571
    [No Abstract]   [Full Text] [Related]  

  • 51. Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening.
    Beuhler KO; D'Lima DD; Colwell CW; Otis SM; Walker RH
    Clin Orthop Relat Res; 1999 Apr; (361):168-77. PubMed ID: 10212610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty.
    Sarmiento A; Goswami AD
    J Bone Joint Surg Am; 1999 Mar; 81(3):339-46. PubMed ID: 10199271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspirin therapy should be first-line treatment in secondary prevention of stroke--against.
    Diener HC
    Stroke; 2002 Aug; 33(8):2138-9. PubMed ID: 12154277
    [No Abstract]   [Full Text] [Related]  

  • 56. Aspirin in secondary prevention of recurrent venous thromboembolism.
    Boonyawat K; Crowther MA
    J Thromb Thrombolysis; 2015 Apr; 39(3):392-4. PubMed ID: 25740464
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.
    Turpie AG
    Am J Cardiol; 2000 Dec; 86(12B):48M-52M. PubMed ID: 11206019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEP trial. Pulmonary Embolism Prevention.
    Tauzeeh SM
    Lancet; 2000 Jul; 356(9225):248; author reply 250-1. PubMed ID: 10963218
    [No Abstract]   [Full Text] [Related]  

  • 59. Thromboprophylaxis for patients at high risk of VTE.
    Lowe G
    Lancet; 2008 Sep; 372(9643):1037-8. PubMed ID: 18805329
    [No Abstract]   [Full Text] [Related]  

  • 60. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.